Search
Search Results
##search.searchResults.foundPlural##
-
The Outcome of Six Patients with COVID-19 Infection and Multiple Myeloma. A Case Series and Literature Review COVID-19 in Multiple Myeloma patients
1039PDF: 382HTML: 236 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7752PDF: 2460HTML: 2101Table 1.: 233Table 2.: 242Table 3.: 225Table 4.: 218 -
-
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2222PDF: 1759HTML: 820 -
CYTOMEGALOVIRUS REACTIVATION IN ADULT RECIPIENTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE
1580PDF: 903HTML: 1011figures: 201table 1: 201table2: 198table3: 201 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2406PDF: 1691HTML: 427 -
Aberrant acquisition of T-cell associated markers in plasma cell neoplasms: An aggressive disease with extramedullary involvement and very short survival Aberrant T markers on malignant plasma cells
1842PDF: 424HTML: 225 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2674PDF: 1653HTML: 2440Table1: 205 -
Hsa-miR-5581-3p and hsa-miR-542-3p target the F8 gene in hemophilia A without F8 mutations F8 gene is regulated by miRNAs
1166PDF: 520HTML: 380 -
-
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
1703PDF: 817HTML: 223 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
3176PDF: 938HTML: 2505 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1430PDF: 882HTML: 223 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1447PDF: 842HTML: 3127 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2186PDF: 1030HTML: 4088Cover Letter: 232Figure 1: 243Figure 2: 241Table 1: 214 -
HEMATOLOGY PATIENT PROTECTION DURING THE COVID-19 PANDEMIC IN ITALY: A NATIONWIDE NURSING SURVEY Hematology patient protection during the COVID-19
1689PDF: 618HTML: 281 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4522PDF: 1755HTML: 1136 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4130PDF: 1175HTML: 2101Fig.1: 224Fig. 2: 120Table 1: 212Table2: 232Table 3: 208 -
CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES CAR-T CELL FOR T-CELL MALIGNANCIES
2253PDF: 2083HTML: 207 -
CRYOGLOBULIN TEST AND CRYOGLOBULINEMIA HEPATITIS C-VIRUS RELATED
4018PDF: 1334HTML: 2483 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
2140PDF: 739HTML: 2142Untitled: 234Untitled: 163Untitled: 187Untitled: 167Untitled: 181Untitled: 195Untitled: 195 -
Azacytidine failure revisited: an appraisal based on real life data from the MDS registry of the Hellenic Myelodysplastic Syndrome Study Group (HMDS). Azacytidine failure revisited
1129PDF: 889HTML: 280 -
COVID-19-associated cold agglutinin syndrome and hemophagocytic phenomenon in a patient with monoclonal gammopathy of undetermined significance COVID-19-associated cold agglutinin syndrome and hemophagocytic phenomenon
1093PDF: 850HTML: 449 -
COST OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN INDIA
2816PDF: 994HTML: 4718







